ArticlePlastic and reconstructive surgery. Global open2025
Use of NovoSorb Biodegradable Temporizing Matrix for Reconstruction of Scrotal Fournier Gangrene Wound.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 55-year-old man presented with a diagnosis of Fournier gangrene of the groin and genitals. Surgical debridement resulted in full-thickness wounds requiring reconstruction. NovoSorb Biodegradable Temporizing Matrix is a bilayer biodegradable dermal matrix developed in recent years to provide a synthetic option for wound reconstruction. We demonstrate a novel method for managing a Fournier gangrene wound using a 1-stage advancement flap combined with NovoSorb Biodegradable Temporizing Matrix to achieve reconstruction without the need for split-thickness skin grafting. The resulting postoperative wound demonstrated a good clinical outcome without complications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.